What age should you start Density or XERF? — what matters more than age
“I am in my 30s — is it too soon?” “I am in my 50s — is it too late?” Many questions start with age. No study has reported Density or XERF results by age group, and the factor that predicted response to RF lifting was not age.
The short answer
Whether Density or XERF is appropriate depends not on age but on whether sagging is present now and how lax the tissue is. In a 25-person RF lifting study, the factor that predicted results was tissue mobility, and age was not significant (the sample is small). Mean age was 49.4 in the Density data and 44–52 in ultrasound lifting clinical studies, so data for people in their 20s and 30s and for those over 60 are especially thin. So someone in their 30s can be a candidate for Density or XERF if the jawline has started to blur, and for someone in their 50s whose main problem is lost volume, Density or XERF is not the first step (clinical judgement).
How old were the people in Density and XERF studies?
| Data | Age | Results by age |
|---|---|---|
| Density, 16 people (2025) | Mean 49.4 ± 6.1 | Not reported |
| XERF, 20 people (Hwang 2025) | 28–63 | Not reported |
| XERF, 39 people (Weiss 2026) | Mean 54.4 | Not reported |
| Ultrasound lifting clinical studies (e.g. Ulthera) | Mean 44–52 | Three large reviews all report no results by age |
We could not find any study that directly tested “lifting in your 30s” or “lifting in your 50s” by decade, for Density, XERF or any other device. Facial ageing studies also group 41–64 together or compare 54-plus with 75-plus, without separating the 40s from the 50s.
If not age, what decides Density and XERF results?
In a 25-person RF lifting study (mean age 52.3, 12 months), response was predicted by tissue mobility — how lax and movable the tissue is — and age was not a significant predictor. The sample is small, so the study had limited power to detect an age effect, and it was not a study of Density or XERF.
So Miso Clinic looks at three things before age — whether there is sagging, whether the skin has thinned, and whether volume has been lost. Even among people in their 40s, depending on this combination Density or XERF may or may not come first.
Density and XERF: situations we often see by age group
| Age group | Common situation | Density or XERF decision |
|---|---|---|
| 20s | Concerns are more often texture, acne scars and pores than sagging | Density or XERF not first if there is no sagging |
| 30s | Jawline starting to blur — the least-studied age group | Density or XERF a candidate if sagging is visible; avoid high expectations |
| 40s | Sagging and skin thinning begin together | Density or XERF a candidate if sagging dominates; plan the order with boosters for thinning |
| 50s | Around the menopausal transition (mean about 49–50 in Korean women), with volume change | Density or XERF not first if lost volume dominates |
| 60s and over | Skin lax enough to fold | Surgical consultation if beyond the range of non-surgical devices such as Density or XERF |
This Density and XERF age-group table is not a study result but clinical judgement summarising situations common in the clinic. Individual variation is greater than variation by age group.
Is it better to start Density or XERF early?
We could not find any study in people confirming the claim that “starting Density, XERF or other lifting early slows ageing”. The 2026 study cited for this claim was computer modelling with no actual people, and all groups converged by year 15.
There are also no data showing that regular preventive Density or XERF without sagging is beneficial, so Miso Clinic recommends starting when sagging becomes visible.
Density, XERF and age summary
What is established
- Density data mean age 49.4; XERF 28–63 · mean 54.4 — no results by age
- The predictor of RF lifting response was tissue mobility; age was not significant (25 people)
- Mean age at natural menopause in Korean women about 49–50
What we could not find
- Density or XERF results in people in their 20s–30s or over 60
- Comparative studies showing different Density or XERF settings are needed by age group
- Long-term benefit of early or preventive treatment (human data)
Density, XERF and age: frequently asked questions
From what age can I have Density or XERF?
No age threshold for Density or XERF has been set by research. The factor that predicted response to RF lifting was tissue laxity, not age, and Miso Clinic decides by whether sagging is visible.
I am in my 30s. Can I have Density?
Even in your 30s, you can be a candidate for Density if your jawline has started to blur. But the 30s are the least-studied age group in lifting research, so the data for predicting Density results in numbers are thin.
Can I use XERF in my 20s for prevention?
We could not find human data showing that preventive RF lifting such as XERF benefits people in their 20s without sagging. Concerns about texture, pores or scars in the 20s are better matched by other treatments than XERF.
Does it work in my 50s or 60s?
XERF studies included people up to 63, but there are no results by age. If lost volume is the main problem or the skin is lax enough to fold, Density or XERF is not the first step.
Read next
Product pages
Who wrote this
Written and reviewed by Lee Chi-Hak, MD, medical director of Miso Clinic in Daegu, South Korea. Every study cited above is given together with its design, its size and the limitations the authors themselves recorded, and where we could not find data, we have said that we could not find any.
| Medical director | Lee Chi-Hak, MD |
|---|---|
| Address | 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea · Exit 1, Kyungpook National University Hospital Station |
| Phone | +82-53-428-2700 |
| Hours | Weekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays |
| Columns | All clinical columns |
| Reference library | All booster and device references |
References
- What predicted response — Sasaki G et al., Aesthetic Surg J 2007;27(4):376–387 (25 subjects, mean age 52.3, 12 months). Only tissue mobility was significant; age was not a significant predictor. The sample is small.
- The gap in age data — mean age in ultrasound lifting clinical studies 44–52; three large reviews (Amiri 2025 · Haykal 2025 · Modena 2025) all report no results by age. Mean age at natural menopause in Korean women about 49–50 (Choi B-O et al., Korean J Fam Med 2015; Park YJ et al., 2002).
- Density human data — Oku K, J Cosmet Dermatol 2025;24(10):e70504, PMID 41090512. The paper names DENSITY (Jeisys Medical) in the main text. 16 Japanese adults (1 man · 15 women, mean age 49.4 ± 6.1) · one session of about 500–600 shots · 24 weeks · no control group · single author. Tightening 0.82 mm, lower-face thickness −0.89 mm, GAIS improved in 15 of 16, pain 1.4/5, no burns, persistent erythema or scarring reported. The abstract (0.82 ± 0.36) and the main text (± 0.34) give different values.
- Three XERF human studies — Hwang JK, Medical Lasers 2025;14(1):23–30 (20 subjects · one session · 12 weeks) · Weiss RA et al., Cureus 2026;18(3):e104546, PMID 41930066 (39 subjects · two sessions · 90 days, manufacturer support) · Erlich G et al., Lasers Med Sci 2026;41(1), PMID 42611100 (retrospective, 16 subjects · one session · 3 months). None of the three has a control group.
- Miso Clinic clinical protocols — criteria for indications, design by area, and the explanation and consent process before treatment. The source of the sentences marked “clinical judgement” in this column.
Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.